Massachusetts General Hospital
Cambridge, Massachusetts, 02138, United States
NCT Number: NCT01263756
The proposed pilot study will begin to assess whether driving impairments are included in the functional deficits associated with Autism Spectrum Disorders (ASDs). This will be completed by obtaining data on velocity, collision risk, and visual attention of subjects with ASDs who drive in a simulator. The study includes 2-3 visits for the screening period (approximately 6 hours of assessments) and one driving simulation visit (approximately 2.5 hours). The investigators expect to enroll 20 adolescents and adults (ages 16-50, inclusive) who have been identified as having an ASD from a prior diagnosis or participation in community conferences for individuals with ASDs.
Looking for future studies?
Notify Me16 year–50 year
All sexes
Observational
Cambridge, Massachusetts, 02138, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one-time observation (3 hour assessment)
Data will be obtained on velocity, collision risk, and visual attention of subjects with ASDs who drive in the driving simulator at the Massachusetts Institute of Technology (MIT).
Time frame: one-time assessment (2-6 hour screening visit)
Subjects with ASD will complete two questionnaires, the Driver Behavior Questionnaire and the Driving History Questionnaire, to provide data on the frequency of violations, errors, accidents, and other aspects of driving history and behavior.
Massachusetts General Hospital
Other
A Study of the Driving Performance of Individuals With Autism Spectrum Disorders
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01808066
Asperger Syndrome, Asperger's Disorder
Athens, Ohio, United States
View Trial DetailsNCT04654260
Aberrant Motor Behavior in Dementia, Aggression
New Haven, Connecticut, United States
View Trial DetailsNCT06303791
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyper Activity
Valencia, Spain
View Trial DetailsNCT07571434
Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder with Hyperactivity
Quito, Ecuador
View Trial Details